Most supplements treat the symptom.
We treat the cause.
Upstream means acting on the root cause before symptoms become damage. It is the only position worth owning in nutrition.
Joint pain doesn't start in your joints.
The supplement industry has spent decades targeting joints directly — glucosamine for cartilage, collagen for tissue, anti-inflammatories for pain. All of it downstream. All of it treating consequences rather than causes.
The research now points somewhere different. For a significant proportion of people, the inflammation that damages joints originates in the gut. A compromised gut barrier allows inflammatory triggers into the bloodstream. They circulate. They land in connective tissue and joints. The gut was the problem. The joint is just where you feel it.
Upstream means addressing that. Not waiting for the joint to deteriorate and then managing it — but supporting the system that drives the problem in the first place, while the window to act is still open.
One sachet.
Both ends of the chain.
LYVA Flex is a daily sachet that addresses the gut-joint axis at both ends. Gut barrier support to close the upstream leak. Joint-focused anti-inflammatory ingredients to address the downstream environment. Clinical-grade forms. Doses that match the trials.
Not a gut health product. Not a joint product. A product that understands the two are connected — and formulated accordingly.
See LYVA Flex →Gut barrier support
Prebiotic blend and L-glutamine support the intestinal lining — reducing the permeability that lets inflammatory triggers into circulation.
Microbiome modulation
Berberine and artichoke leaf support a healthy gut microbiome composition — the upstream driver of the short-chain fatty acids that protect cartilage and subchondral bone.
Joint environment support
Curcumin BCM-95, Boswellia, and quercetin address the inflammatory environment at the joint — in clinical-grade, bioavailable forms at doses the trials actually used.
Mechanism first.
Marketing second.
Always.LYVA · Upstream